Organization
Priovant Therapeutics
4 clinical trials
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Oral Brepocitinib in Adults With DermatomyositisStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase 2 Randomized, Double-Masked, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active Non-Infectious Intermediate-, Posterior-, and PanuveitisStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and PanuveitisStatus: Not yet recruiting, Estimated PCD: 2026-08-23
Clinical trial
A 12-Week Open-Label Pilot Study to Investigate the Efficacy and Safety of Oral Brepocitinib in Adults With Skin-Predominant DermatomyositisStatus: Not yet recruiting, Estimated PCD: 2024-12-01